NCT02968069Not yet recruiting
A Predictive Model Based on Narrow Band Imaging for Early Gastric Cancerous Lesions
Development and Validation of a Predictive Model for Early Gastric Cancerous Lesions Under Endoscopic Observation
Source: ClinicalTrials.gov · Last updated 2 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Without high diagnostic efficacy of endoscopic forceps biopsy (EFB) and with low diagnostic efficacy of narrow band imaging (NBI) in novice endoscopists and endoscopists of community hospitals in China, it is urgent to improve diagnostic efficacy for gastric cancerous lesions.The investigators will conduct a study to develop and validate a diagnostic model based on NBI for early gastric cancerous lesions under endoscopic observation.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 11 Nov 2016
- Start date
- Oct 2025
- Primary completion date
- Oct 2026
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT02968069
What you commit to
- Study type: Interventional
- Planned participants: 300
- From Oct 2025 to the primary completion date, Oct 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinical diagnosis of advanced gastric cancer
- Acute upper gastrointestinal bleeding
- Severe systemic diseases
Other
- Refuse to attend the study
Who the study is looking for
- Suspected of having a cancerous lesions
- The age of patients is from 40-80 years
- Patients must undergo esophagogastroduodenoscopy
Age in the registry: 20 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.